Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306366813> ?p ?o ?g. }
- W4306366813 endingPage "4920" @default.
- W4306366813 startingPage "4902" @default.
- W4306366813 abstract "The available evidence suggests that affective disorders, such as depression and anxiety, increase risk for accelerated cognitive decline and late-life dementia in aging individuals. Behavioral neuropsychology studies also showed that cognitive decline is a central feature of aging impacting the quality of life. Motor deficits are common after traumatic brain injuries and stroke, affect subjective well-being, and are linked with reduced quality of life. Currently, restorative therapies that target the brain directly to restore cognitive and motor tasks in aging and disease are available. However, the very same drugs used for therapeutic purposes are employed by athletes as stimulants either to increase performance for fame and financial rewards or as recreational drugs. Unfortunately, most of these drugs have severe side effects and pose a serious threat to the health of athletes. The use of performance-enhancing drugs by children and teenagers has increased tremendously due to the decrease in the age of players in competitive sports and the availability of various stimulants in many forms and shapes. Thus, doping may cause serious health-threatening conditions including, infertility, subdural hematomas, liver and kidney dysfunction, peripheral edema, cardiac hypertrophy, myocardial ischemia, thrombosis, and cardiovascular disease. In this review, we focus on the impact of doping on psychopathological disorders, cognition, and depression. Occasionally, we also refer to chronic use of therapeutic drugs to increase physical performance and highlight the underlying mechanisms. We conclude that raising awareness on the health risks of doping in sport for all shall promote an increased awareness for healthy lifestyles across all generations." @default.
- W4306366813 created "2022-10-17" @default.
- W4306366813 creator A5028410367 @default.
- W4306366813 creator A5036873610 @default.
- W4306366813 creator A5057081490 @default.
- W4306366813 creator A5068091656 @default.
- W4306366813 creator A5077585067 @default.
- W4306366813 creator A5077708026 @default.
- W4306366813 creator A5084135631 @default.
- W4306366813 date "2022-10-15" @default.
- W4306366813 modified "2023-10-18" @default.
- W4306366813 title "Therapeutic Use and Chronic Abuse of CNS Stimulants and Anabolic Drugs" @default.
- W4306366813 cites W121396365 @default.
- W4306366813 cites W149078058 @default.
- W4306366813 cites W1535440993 @default.
- W4306366813 cites W1816695864 @default.
- W4306366813 cites W1825290601 @default.
- W4306366813 cites W1969111404 @default.
- W4306366813 cites W1977747054 @default.
- W4306366813 cites W1979056400 @default.
- W4306366813 cites W1985813433 @default.
- W4306366813 cites W1987905591 @default.
- W4306366813 cites W1990674160 @default.
- W4306366813 cites W1996599358 @default.
- W4306366813 cites W2007129533 @default.
- W4306366813 cites W2008253937 @default.
- W4306366813 cites W2008388130 @default.
- W4306366813 cites W2009631046 @default.
- W4306366813 cites W2010217187 @default.
- W4306366813 cites W2016566711 @default.
- W4306366813 cites W2019256317 @default.
- W4306366813 cites W2022644027 @default.
- W4306366813 cites W2027165993 @default.
- W4306366813 cites W2028015324 @default.
- W4306366813 cites W2031196279 @default.
- W4306366813 cites W2037240211 @default.
- W4306366813 cites W2040451694 @default.
- W4306366813 cites W2044092606 @default.
- W4306366813 cites W2046360192 @default.
- W4306366813 cites W2052226124 @default.
- W4306366813 cites W2052590556 @default.
- W4306366813 cites W2054423368 @default.
- W4306366813 cites W2063972644 @default.
- W4306366813 cites W2065112809 @default.
- W4306366813 cites W2071723765 @default.
- W4306366813 cites W2072956511 @default.
- W4306366813 cites W2073266477 @default.
- W4306366813 cites W2086365509 @default.
- W4306366813 cites W2086803670 @default.
- W4306366813 cites W2086804271 @default.
- W4306366813 cites W2088730698 @default.
- W4306366813 cites W2089043139 @default.
- W4306366813 cites W2089725106 @default.
- W4306366813 cites W2090108889 @default.
- W4306366813 cites W2092483615 @default.
- W4306366813 cites W2093295906 @default.
- W4306366813 cites W2093321137 @default.
- W4306366813 cites W2098079895 @default.
- W4306366813 cites W2099631417 @default.
- W4306366813 cites W2101763810 @default.
- W4306366813 cites W2103488444 @default.
- W4306366813 cites W2106757561 @default.
- W4306366813 cites W2108025392 @default.
- W4306366813 cites W2110214688 @default.
- W4306366813 cites W2118881240 @default.
- W4306366813 cites W2119903929 @default.
- W4306366813 cites W2120548621 @default.
- W4306366813 cites W2124951891 @default.
- W4306366813 cites W2128495208 @default.
- W4306366813 cites W2129236397 @default.
- W4306366813 cites W2134720732 @default.
- W4306366813 cites W2134930941 @default.
- W4306366813 cites W2135372774 @default.
- W4306366813 cites W2140658948 @default.
- W4306366813 cites W2142844621 @default.
- W4306366813 cites W2143794453 @default.
- W4306366813 cites W2144875128 @default.
- W4306366813 cites W2147442229 @default.
- W4306366813 cites W2148489202 @default.
- W4306366813 cites W2149615621 @default.
- W4306366813 cites W2149637082 @default.
- W4306366813 cites W2149862521 @default.
- W4306366813 cites W2152952868 @default.
- W4306366813 cites W2156717193 @default.
- W4306366813 cites W2159534445 @default.
- W4306366813 cites W2162055755 @default.
- W4306366813 cites W2162798214 @default.
- W4306366813 cites W2166288516 @default.
- W4306366813 cites W2168124527 @default.
- W4306366813 cites W2168793596 @default.
- W4306366813 cites W2194633751 @default.
- W4306366813 cites W2205789894 @default.
- W4306366813 cites W2219559188 @default.
- W4306366813 cites W2261793840 @default.
- W4306366813 cites W2278611179 @default.
- W4306366813 cites W2302844697 @default.
- W4306366813 cites W2314874570 @default.
- W4306366813 cites W2340884663 @default.